KRAS and cancer: In summary, this study underscores the evolving role of polymeric nanoparticles in advancing mRNA-based therapies, offering more possibilities for polymer-based CRISPR delivery systems aimed at targeting oncogenic mutations such as KRAS in cancer treatment.